Nemaura Medical, Inc.
$0.0002
Stock Quotes & Analysis
NMRD100.00%
$0.0002
Latest AAPL News (Need to figure out how to make this dynamic)
test
Graphene is an excellent conductor of electricity and heat, surpassing traditional materials like silicon, and…
The political winds are shifting, and Wall Street is taking notice. As Donald Trump’s approval…
In the shadows of Silicon Valley’s AI frenzy, a sleeping giant is awakening. While tech…
Nemaura Medical, Inc.Status: Active
Sector: Healthcare
Industry: Medical Devices
Symbol: NMRD
Exchange: OEM
Employees: 36
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
 | 57 West 57th Street, New York, NY, United States |
 | 646 416 8000 |
 | https://nemauramedical.com |